|
Index of reports
> Serious Events (1186)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) serious events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 1186 Next >>
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Renal Impairment, Anaemia, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-24
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-25
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-17
Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Pancreatitis Acute, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-15
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-20
Telaprevir
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-20
Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise, Renal Impairment, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-06
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-20
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-21
End date: 2012-07-12
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-14
Rebetol
Dosage: 200 mg, qod
Administration route: Oral
Start date: 2012-07-13
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-06-08
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-07
Other drugs received by patient: Lendormin; Lansoprazole; Amoban
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qam
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Rebetol
Dosage: unk unk, qpm
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-31
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.8 microgram per kilogram, qw
Start date: 2012-05-08
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-24
PEG-Intron
Dosage: 1.0 microgram per kilogram, qw
Start date: 2012-05-01
End date: 2012-05-01
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-07-12
Other drugs received by patient: Claritin; Ferotym; Livalo; Epadel S
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-02-07
Peginterferon Alfa-2B
Dosage: 1.0 ?g/kg, qw
Start date: 2012-02-15
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-01-31
End date: 2012-02-08
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-15
End date: 2012-07-11
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-09
End date: 2012-02-14
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-04-24
Other drugs received by patient: Ferotym; Epadel S; Etizolam; Norvasc; Depas; Claritin Reditabs; Livalo
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Germany on 2012-08-27
Patient:
Reactions: Maternal Exposure Before Pregnancy, Abortion Induced
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis
End date: 2012-01-01
Rebetol
Dosage: unk
End date: 2012-01-01
Victrelis
Dosage: 200 mg, qd
Indication: Hepatitis
Start date: 2012-01-09
End date: 2012-05-01
Other drugs received by patient: Lexotanil
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-15
End date: 2012-07-13
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Other drugs received by patient: Diflunisal; Januvia; Basen
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from Colombia on 2012-08-27
Patient:
Reactions: Pallor, Asthenia
Drug(s) suspected as cause:
Pegasys
Rebetol
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-10
End date: 2012-08-01
Other drugs received by patient: Epoetin
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Interstitial Lung Disease, Oedema, Hepatic Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, once
Administration route: Oral
Indication: Adverse Event
End date: 2012-06-09
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Rebetol
Dosage: 800 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Other drugs received by patient: Urso 250; Lasix; Celestamine TAB; NEO-Minophagen C; Aldactone
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 30 microgram per kilogram, qw
Start date: 2012-07-05
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-21
PEG-Intron
Dosage: 50 microgram per kilogram, qw
Start date: 2012-07-12
PEG-Intron
Dosage: 70 microgram per kilogram, qw
Start date: 2012-07-19
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-07-05
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Fatigue, Vomiting, Pruritus, Diarrhoea, Dehydration, Ephelides
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: 180 microgram, qw
Start date: 2012-03-24
Rebetol
Dosage: 1200 mg, qd
Administration route: Oral
Start date: 2012-03-24
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-21
Other drugs received by patient: Metformin HCL
Possible Rebetol side effects in
Reported by a pharmacist from Spain on 2012-08-27
Patient:
Reactions: Anaemia, Neutropenia
Drug(s) suspected as cause:
Pegasys
Dosage: semanal
Start date: 2011-09-29
Rebetol
Dosage: 1200/dia y pegasys semanal.
Administration route: Oral
Start date: 2011-09-29
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Generalised Erythema
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Start date: 2012-05-08
End date: 2012-05-14
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-05-15
Rebetol
Dosage: 1000 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-05-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-03
End date: 2012-07-05
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-06-11
Other drugs received by patient: Norvasc; Rinderon V; Allopurinol; Hirudoid; Xyzal; Allopurinol; Prednisolone; Rabeprazole Sodium; Rabeprazole Sodium; [composition Unspecified]; Clobetasol Propionate; Sitagliptin Phosphate
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.1 ?g/kg, qw
Start date: 2012-04-06
End date: 2012-04-19
Peginterferon Alfa-2B
Dosage: 1.4 ?g/kg, unknown
Start date: 2012-04-20
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-02-03
Peginterferon Alfa-2B
Dosage: 1.4 ?g/kg, qw
End date: 2012-04-05
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-03
End date: 2012-04-26
Other drugs received by patient: Loxonin; Diclofenac Sodium
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Bronchitis
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: 180 micrograms/meter
Indication: Hepatitis C
Rebetol
Dosage: 200 mg, unk
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis
Other drugs received by patient: Lamotrigine; Fish OIL; Melatonin; Hydrocodone Bitartrate; Nexium; Clonazepam; Zofran
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Psychiatric Symptom
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-16
Rebetol
Dosage: cumulative dose: 20000 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-13
Rebetol
Dosage: cumulative dose: 20000 mg
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-16
Telavic
Dosage: cumulative dose: 56250 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-16
Other drugs received by patient: Loxoprofen; Allopurinol
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-07
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-25
End date: 2012-07-30
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-06-24
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-07-08
Other drugs received by patient: Loxonin; Olopatadine HCL; Allopurinol; Betamethasone Sodium Phosphate
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg /kg/week
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-25
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-06-26
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-04-26
End date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-24
Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram, qw
Start date: 2012-05-02
End date: 2012-05-02
PEG-Intron
Dosage: 40 microgram, qw
Start date: 2012-06-06
End date: 2012-06-20
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-04-18
End date: 2012-04-18
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-11
PEG-Intron
Dosage: 30 microgram,
Start date: 2012-06-27
End date: 2012-06-27
PEG-Intron
Dosage: 75 microgram, qw
Start date: 2012-04-25
End date: 2012-04-25
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-05-09
End date: 2012-05-30
PEG-Intron
Dosage: 40 microgram, unk
Start date: 2012-07-04
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-14
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
End date: 2012-06-27
Telavic
Dosage: unk
Administration route: Oral
Start date: 2012-04-17
Other drugs received by patient: Glycyron; Talion (Bepotastine Besylate); Loxonin; Loxonin; Urso 250; NEO-Minophagen C; Motilium
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Start date: 2012-06-19
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-19
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-03
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Start date: 2012-06-19
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-25
Patient:
Reactions: Blood Uric Acid Increased, Pancytopenia
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Start date: 2012-06-14
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-03-15
End date: 2012-05-31
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-15
End date: 2012-05-01
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-02
End date: 2012-06-06
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-14
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-15
End date: 2012-05-23
Telavic
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-05-24
End date: 2012-06-07
Other drugs received by patient: [therapy Unspecified]; Pursennid (Sennosides); Confatanin; Clobetasol Propionate; Hustazol (Cloperastine Hydrochloride)
Possible Rebetol side effects in
Reported by a pharmacist from Japan on 2012-08-25
Patient:
Reactions: Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.75 microgram per kilogram, unk
Start date: 2012-07-16
PEG-Intron
Dosage: 1.5mcg/kg
Start date: 2012-07-09
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-07-09
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Start date: 2012-07-09
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-13
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-25
Patient:
Reactions: Pleurisy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram per kilogram, 5 times a week
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-25
Patient:
Reactions: Rash Erythematous
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg/kg
Indication: Hepatitis C
Rebetol
Dosage: 1 g, qd
Administration route: Oral
Indication: Hepatitis C
Telavic
Dosage: 2.25 g, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-04
Other drugs received by patient: Rabeprazole Sodium; Talion (Bepotastine Besylate); Amlodipine Besylate; Loxonin
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-25
Patient:
Reactions: Neutrophil Count Decreased
Drug(s) suspected as cause:
Interferon Beta NOS
Dosage: 6 million iu, tiw
Start date: 2011-04-01
Interferon Beta NOS
Dosage: 6 million iu, qd
Indication: Hepatitis C
Start date: 2011-03-17
End date: 2011-03-30
Rebetol
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-04-15
Rebetol
Dosage: 200 mg in morning, 400 mg in evening
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-17
End date: 2011-04-14
Other drugs received by patient: Napa (Acetaminophen); Rheumatrex; Prograf; Lansoprazole; Depas; Napa (Acetaminophen)
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-25
Patient:
Reactions: Gastrointestinal Haemorrhage, Anaemia, Haematemesis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2011-11-02
End date: 2012-06-27
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-02
End date: 2012-05-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-29
End date: 2012-06-30
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Start date: 2012-05-14
End date: 2012-05-22
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-23
End date: 2012-06-30
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-05-11
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-25
Patient:
Reactions: Anaemia, Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-12
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-07-02
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-07-01
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Diltiazem Hydrochloride; Livalo; Epadel S; Ferotym
Page 1 Next >>
|
